BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $765 | -26.5% | 20,264 | -11.3% | 0.06% | -25.3% |
| Q2 2023 | $1,041 | +6.0% | 22,849 | -5.6% | 0.09% | +1.2% |
| Q1 2023 | $982 | -18.5% | 24,200 | +2.4% | 0.09% | -22.5% |
| Q4 2022 | $1,205 | -99.9% | 23,641 | +8.0% | 0.11% | -5.1% |
| Q3 2022 | $1,179,000 | -17.3% | 21,886 | -1.4% | 0.12% | -10.7% |
| Q2 2022 | $1,426,000 | -17.2% | 22,196 | -0.0% | 0.13% | -3.0% |
| Q1 2022 | $1,722,000 | -9.9% | 22,206 | -0.3% | 0.14% | -8.8% |
| Q4 2021 | $1,912,000 | +11.7% | 22,278 | +4.7% | 0.15% | +2.8% |
| Q3 2021 | $1,712,000 | -0.9% | 21,288 | -0.8% | 0.14% | +5.1% |
| Q2 2021 | $1,727,000 | -11.5% | 21,458 | -7.3% | 0.14% | -18.5% |
| Q1 2021 | $1,951,000 | +18.0% | 23,136 | +12.2% | 0.17% | +5.7% |
| Q4 2020 | $1,654,000 | +10.0% | 20,614 | +10.2% | 0.16% | -3.0% |
| Q3 2020 | $1,504,000 | -1.1% | 18,703 | +6.0% | 0.16% | -10.4% |
| Q2 2020 | $1,520,000 | +7.3% | 17,651 | +1.2% | 0.18% | -1.1% |
| Q1 2020 | $1,416,000 | -1.7% | 17,436 | +1.2% | 0.18% | +29.4% |
| Q4 2019 | $1,441,000 | -4.4% | 17,236 | 0.0% | 0.14% | -18.8% |
| Q3 2019 | $1,508,000 | +6.8% | 17,236 | 0.0% | 0.18% | +5.4% |
| Q2 2019 | $1,412,000 | +0.8% | 17,236 | 0.0% | 0.17% | +1.8% |
| Q1 2019 | $1,401,000 | +16.9% | 17,236 | -5.3% | 0.16% | +2.5% |
| Q4 2018 | $1,198,000 | -15.0% | 18,200 | -0.5% | 0.16% | -3.6% |
| Q3 2018 | $1,410,000 | +4.4% | 18,296 | 0.0% | 0.17% | -2.4% |
| Q2 2018 | $1,351,000 | +13.5% | 18,296 | 0.0% | 0.17% | +11.8% |
| Q1 2018 | $1,190,000 | -0.7% | 18,296 | -1.3% | 0.15% | +16.9% |
| Q4 2017 | $1,198,000 | +3.0% | 18,540 | 0.0% | 0.13% | -1.5% |
| Q3 2017 | $1,163,000 | +3.7% | 18,540 | 0.0% | 0.13% | +3.9% |
| Q2 2017 | $1,122,000 | +16.8% | 18,540 | 0.0% | 0.13% | +13.4% |
| Q1 2017 | $961,000 | +9.1% | 18,540 | -6.7% | 0.11% | +5.7% |
| Q4 2016 | $881,000 | -7.1% | 19,870 | -0.2% | 0.11% | -8.6% |
| Q3 2016 | $948,000 | +2.2% | 19,912 | -3.0% | 0.12% | -1.7% |
| Q2 2016 | $928,000 | -4.4% | 20,520 | -13.2% | 0.12% | -5.6% |
| Q1 2016 | $971,000 | +2.6% | 23,646 | -4.6% | 0.12% | +4.2% |
| Q4 2015 | $946,000 | +10.0% | 24,784 | -5.3% | 0.12% | +6.2% |
| Q3 2015 | $860,000 | -53.5% | 26,184 | -1.0% | 0.11% | -47.2% |
| Q2 2015 | $1,849,000 | +0.9% | 26,437 | -1.2% | 0.21% | 0.0% |
| Q1 2015 | $1,833,000 | -13.8% | 26,762 | -7.8% | 0.21% | -15.7% |
| Q4 2014 | $2,127,000 | +9.1% | 29,021 | +6.8% | 0.25% | +7.2% |
| Q3 2014 | $1,949,000 | -25.6% | 27,162 | -25.0% | 0.24% | -29.3% |
| Q2 2014 | $2,619,000 | -3.1% | 36,227 | -1.4% | 0.34% | -8.2% |
| Q1 2014 | $2,702,000 | +1.6% | 36,727 | -3.9% | 0.36% | +0.6% |
| Q4 2013 | $2,659,000 | +7.0% | 38,227 | +1.1% | 0.36% | -1.1% |
| Q3 2013 | $2,485,000 | -1.5% | 37,827 | +3.8% | 0.37% | -10.5% |
| Q2 2013 | $2,523,000 | – | 36,427 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |